InvestorsHub Logo
Followers 23
Posts 3078
Boards Moderated 0
Alias Born 07/15/2016

Re: StevenRisk post# 36923

Tuesday, 09/19/2017 10:12:02 AM

Tuesday, September 19, 2017 10:12:02 AM

Post# of 65782
There are some things that are not 100% clear. Shares outstanding could be preferred as well as common. I may have mis-read the PR thinking that was o/s which inherently refers to common stock.

If I referred you to the '14' I'm not sure why you would take offense. I recall you having questions about the preferred structure and conversion rate. It was impossible to explain on a post the chart in the 14 showing the entire structure was the only way to make sense of the old share structure.

As I kept saying pref shares were alphabet soup in the old structure. A-E all having different conversion rates and now everything is 1:1 unless I see something different.

B.O.Ds hold ~13M in voting rights so once outstanding reaches 26M+ they lose controlling stake. a/s is 110M so I'm not sure how they will expand much further than that safely. Either an equity partner or a merger as they've done in the past of trading shares for labs.

PalliaTech has given up 2 labs so far. One in CO and one in MA. I wonder if there will be a partnership or even a full merger there.


EVIO is exploring cannabis plant science and genetic research opportunities, and considering opportunities in legal cannabis marketplaces around the world.